Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during November 2025'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has submitted a routine regulatory filing to the NSE reporting the number of shares that were converted from physical certificates into electronic (demat) form during November 2025. Dematerialization is a standard, ongoing process where investors move their paper share certificates into digital holdings with a depository. This disclosure is a regular compliance requirement for listed companies and does not involve any new issuance, buyback, or change in share capital. The headline does not specify the exact count of shares dematerialized.
This is a routine administrative update with no material impact on the company's valuation, shareholding pattern, or stock price. It simply reflects the ongoing industry-wide shift from physical to electronic share holdings and requires no action from shareholders.